• Research against cancer
• Research regarding dementia
• Research regarding rare genetic diseases

The intention of the founders of the Fondation SigMu is to finance those areas of scientific health research that generally attract less interest from donors. Furthermore, they are sensitive to the fact that the pharmaceutical industry frequently neglects research when it is considered not being commercially viable. As a consequence, scientific research regarding certain rare diseases is fully dependent on the generosity of donors.

By reinforcing the research capacity in the above mentioned areas in Luxembourg and eventually in Europe as a whole, the founders of the sheltered Fondation SigMu hope to prevent deceases and improve the living conditions of those already affected.